Self administered, complete hypo treatment

Hypoglycaemia (also known as a hypo, low blood sugar or low blood glucose) is a condition that occurs when a person’s blood glucose level (BGL) drops below a safe range. A hypo can occur suddenly, without warning, and this is a medical emergency.

On average, there are 7 newly diagnosed people with type 1 diabetes in Australia every day.

There is no TGA approved, complete treatment for those living with diabetes at risk of hypoglycaemia.

GDR is researching an evidence-based, new model of care for treating hypos. A new 2 step solution will undergo clinical trials to become the only TGA approved, complete treatment on the market for those living with type 1 diabetes and certain types of type 2 diabetes.

HYPOGLYCAEMIA

_____________

Point of care device, Earlier detection

It is current practice to detect prediabetes in those at risk before it progresses to type 2 diabetes. GDR believes this is too late, and driven by the desire to see better health outcomes and quality of life for those living with or at risk of type 2 diabetes or prediabetes, we believed a point of care (POC) device is needed to provide immediate results at the time of patient consult with GP, or at home using a simple POC device.

A POC medical device is being researched, capable of detecting early insulin resistance in those at risk up to ten years before prediabetes develops, and up to fifteen years before type 2 diabetes develops.

Evidence indicates this will prevent or prolong prediabetes, gestational diabetes and / or the progression to type 2 diabetes by initiating lifestyle changes, education and timely clinical management.

INSULIN RESISTANCE

_____________

Safer weight loss, Combat side effects

Of the 1.3 million people living with type 2 diabetes in Australia, approximately 33% of those are taking GLP-1 weight loss medications. The use of such weight loss drugs (typically used for type 2 diabetes), has become increasingly popular for off-label use, and there are growing concerns around the health risks to people being prescribed these drugs.

Due to the known side effect of a decreased appetite, this class of weight loss drugs can result in extremely rapid weight loss, muscle wastage, and nutritional deficiencies.

There is currently no solution to these side effects, and as such GDR is currently researching a safe solution to mitigate these extreme side effects.

NUTRITIONAL DEFICIENCIES

____________